A leading expert in lung cancer provides insights on recent data and review updates in the treatment landscape for patients with non-small-cell lung cancer and exon 20 insertions.
EP. 1: Overview of Advanced NSCLC with EGFR Mutations Including Exon 20 InsertionsNovember 18th 2021
Zofia Piotrowska, MD, provides an overview of EGFR mutations in advanced NSCLC, including EGFR Exon 20 insertions, and their clinical significance in patients with advanced NSCLC.
EP. 5: Mobocertinib for the Treatment of EGFR Exon 20 Insertions in NSCLCDecember 2nd 2021
Zofia Piotrowska, MD, evaluates the use of mobocertinib in patients with NSCLC and EGFR exon 20 insertions and provides updated results from key trials of mobocertinib in EGFR exon 20-positive NSCLC.